Align Technology, Inc.
ALGN
株式のランク
#1971
Align Technology, Inc. is a medical technology enterprise that develops,... Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.
株価
$150.24
最終同期: 2026-10-20
時価総額
$10.67B
変化（1日）
0.83%
変化（1年）
10.29%
国
US
取引 Align Technology, Inc. (ALGN)
カテゴリー
Healthcare
Align Technology, Inc.（ALGN）のP/E比率
October 2026 時点のP/E比率 TTM 25.08
Align Technology, Inc. の最新の財務報告および株価によると、現在の P/E (TTM) は 25.08 です。2024 年末時点での P/E は 37.05 でした。
Align Technology, Inc. の P/E 比率の履歴（2000 〜 2026）
各年末のP/E比率
| 年 | P/E比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 25.08 | -9.14% |
| 2025 | 27.60 | -25.50% |
| 2024 | 37.05 | -21.25% |
| 2023 | 47.05 | 3.17% |
| 2022 | 45.61 | -32.11% |
| 2021 | 67.18 | 183.46% |
| 2020 | 23.70 | -52.65% |
| 2019 | 50.05 | 19.47% |
| 2018 | 41.89 | -45.51% |
| 2017 | 76.89 | 89.99% |
| 2016 | 40.47 | 10.64% |
| 2015 | 36.58 | 18.14% |
| 2014 | 30.96 | -56.75% |
| 2013 | 71.59 | 88.02% |
| 2012 | 38.07 | 37.29% |
| 2011 | 27.73 | 38.99% |
| 2010 | 19.95 | -150.67% |
| 2009 | -39.38 | -638.75% |
| 2008 | 7.31 | -76.70% |
| 2007 | 31.37 | -224.12% |
| 2006 | -25.27 | -108.95% |
| 2005 | 282.26 | 283.94% |
| 2004 | 73.52 | -255.13% |
| 2003 | -47.39 | 2,511.46% |
| 2002 | -1.81 | -5.45% |
| 2001 | -1.92 | 81.95% |
| 2000 | -1.05 | 0.00% |
類似企業や競合他社のP/E比率
| 企業 | P/E比率 | P/E比率の差 | 国 |
|---|---|---|---|
| 33.11 | 32.03% |
US
|
|
| 21.39 | -14.71% |
IE
|
|
| 28.94 | 15.43% |
US
|
|
| 17.34 | -30.86% |
US
|
|
| - | - |
DE
|
P/E比率の読み方
株価収益率（P/E Ratio）は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の（0に近い）P/Eは、損失が大きいことを示します。
P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。
10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。